Maris-Tech to Showcase Its Innovative Solutions at the Special Operations Forces Week
The annual conference for U.S. and international special operations forces is expected to host more than 15,000 attendees Rehovot, Israel, […]
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
The Company’s neurodegenerative clinical program remains on track, with continued advancement of the Alzheimer’s Phase 2 trial and anticipation of […]
Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers
Successful completion of TVGN 489’s proof-of-concept clinical trial suggested the ability to target and eliminate a virus in high-risk population […]
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
Analysis of eligible1 patients from the sepsis Phase II study (NCT# NCT04612413) In accordance with the study protocol, the safety and […]
Following Share Stake Sale to Executive Chairman Daniel McClory, Alessandro Aleotti to Focus on AleottiLab
DUBLIN, Ireland and MILAN, Italy, April 11, 2024 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings”, “Brera” or the “Company”) […]
Uniti Group Inc. Releases 2023 Environmental, Social and Governance Report
LITTLE ROCK, Ark., April 11, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti” or the “Company”) (Nasdaq: UNIT) announced today […]
AppFolio, Inc. Announces Date of First Quarter 2024 Financial Results Conference Call
SANTA BARBARA, Calif., April 11, 2024 (GLOBE NEWSWIRE) — AppFolio, Inc. (NASDAQ: APPF) today announced that it will report its […]
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
Achieved initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients, which compares favorably to precedent Phase […]
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
WALTHAM, Mass., April 11, 2024 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions […]
Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to […]
